Cardio-Oncology | Home page

Cardio-Oncology | Home page

Cardio-Oncology

Dear Prof CERASALE MORTEO,

As an open access, online journal Cardio-Oncology provides a high visibility platform for the publication of original research and expert reviews on the cardiovascular effects of cancer treatment.

We have selected some recent top articles published in our journal which we think would be of interest to you based on your area of research.

---

Featured Articles

RESEARCH
Persistent PR segment change in malignant pericardial disease
		M. Ahluwalia, R. O’Quinn, B. Ky, D. Callans et al. Abstract   |  Full text   |  PDF

---

REVIEW
Targeting endothelial cell metabolism for cardio-protection from the toxicity of antitumor agents
		Lucia Morbidelli, Sandra Donnini and Marina Ziche et al. Abstract   |  Full text   |  PDF

---

RESEARCH
The interplay between genetic background and sexual dimorphism of doxorubicin-induced cardiotoxicity
		Beshay N. Zordoky, M. Judith Radin, Lois Heller et al. Abstract   |  Full text   |  PDF

---

---

Journal Scope

The editorial mission of Cardio-Oncology is to advance the science and practice of this emerging field to find a balance between oncologic efficacy and reducing adverse cardiovascular effects.

The only journal devoted exclusively to this growing specialty, Cardio-Oncology provides an international forum for communicating the latest findings and state-of-the-art reviews, filling a critical gap in the science and clinical practice of this important field. The journal serves as essential reading for basic researchers, drug developers, adult and pediatric onco-hematologists, cardiologists, radiologists, surgical oncologists, internists, geneticists, epidemiologists, and other health care scientists and providers.

---

Reasons to Publish with Us

•	The only journal devoted exclusively to this emerging specialty
•	Internationally renowned expert Editorial Board
•	Rapid publication for your work

---

---

Submission Guidelines

Register to receive the latest articles, straight to your inbox.

---

Kind regards,

Steven LipshultzEditor-in-Chief, Cardio-Oncology

For further information or enquiries please contact Customer Services at:info@biomedcentral.com.

BioMed Central Ltd 

236 Gray's Inn Road, London, WC1X 8HB, 

United Kingdom.

Contact us

• Editorial email: cardiooncology@biomedcentral.com
• Support email: info@biomedcentral.com

About the Editors

Steven Lipshultz, Editor-in-Chief

Steven Lipshultz is the Schotanus Family Professor and Chair of the Carman and Ann Adams Department of Pediatrics at the Wayne State University School of Medicine, as well as the Pediatrician-in-Chief at the Children’s Hospital of Michigan, the Pediatrics Specialist-in-Chief at the Detroit Medical Center, the President of University Pediatricians, and the Interim Director of the Children’s Research Center of Michigan. His primary research interests are in the pediatric cardiomyopathies, especially those of genetic/metabolic, toxic, or infections/inflammatory etiologies.

Joseph Carver, Deputy Editor

Joseph Carver is the Bernard Fishman Clinical Professor of Medicine at the Abramson Cancer Center of the University of Pennsylvania, the Chief Operating Officer of the Abramson Family Cancer Research Institute of the Abramson Cancer Center of the University of Pennsylvania and the Chief of Staff of the Abramson Cancer Center.

Giorgio Minotti, Deputy Editor

Giorgio Minotti is Professor of Pharmacology, Head of Drug Sciences and Clinical Pharmacology, Chief of Clinical Trial Center, at the University Campus Bio-Medico of Rome. His research interests focus on pharmacokinetics, pharmacodynamics, and clinical correlates of anticancer drugs cardiovascular toxicity.

---